161 related articles for article (PubMed ID: 21081654)
1. Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Li J; Zhang L; Zhou H; Stoneking M; Tang K
Hum Mol Genet; 2011 Feb; 20(3):528-40. PubMed ID: 21081654
[TBL] [Abstract][Full Text] [Related]
2. Population genetic structure of variable drug response.
Wilson JF; Weale ME; Smith AC; Gratrix F; Fletcher B; Thomas MG; Bradman N; Goldstein DB
Nat Genet; 2001 Nov; 29(3):265-9. PubMed ID: 11685208
[TBL] [Abstract][Full Text] [Related]
3. A single-nucleotide polymorphism tagging set for human drug metabolism and transport.
Ahmadi KR; Weale ME; Xue ZY; Soranzo N; Yarnall DP; Briley JD; Maruyama Y; Kobayashi M; Wood NW; Spurr NK; Burns DK; Roses AD; Saunders AM; Goldstein DB
Nat Genet; 2005 Jan; 37(1):84-9. PubMed ID: 15608640
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
Hiratsuka M; Sasaki T; Mizugaki M
Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
[TBL] [Abstract][Full Text] [Related]
5. A nomenclature system for metabolic gene polymorphisms.
Garte S; Crosti F
IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
7. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics and its importance in the clinical].
Lares-Asseff I; Trujillo-Jiménez F
Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
[TBL] [Abstract][Full Text] [Related]
9. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
10. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
12. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
13. Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.
Li J; Lao X; Zhang C; Tian L; Lu D; Xu S
BMC Genet; 2014 May; 15():52. PubMed ID: 24884825
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics: more than skin deep.
McLeod HL
Nat Genet; 2001 Nov; 29(3):247-8. PubMed ID: 11687789
[No Abstract] [Full Text] [Related]
15. Review of studies of selected metabolic polymorphisms and cancer.
d'Errico A; Malats N; Vineis P; Boffetta P
IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
[No Abstract] [Full Text] [Related]
16. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
17. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Kuehl P; Zhang J; Lin Y; Lamba J; Assem M; Schuetz J; Watkins PB; Daly A; Wrighton SA; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Venkataramanan R; Strom S; Thummel K; Boguski MS; Schuetz E
Nat Genet; 2001 Apr; 27(4):383-91. PubMed ID: 11279519
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in cancer etiology and chemotherapy.
Boddy AV; Ratain MJ
Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780
[No Abstract] [Full Text] [Related]
19. Worldwide haplotype diversity and coding sequence variation at human bitter taste receptor loci.
Kim U; Wooding S; Ricci D; Jorde LB; Drayna D
Hum Mutat; 2005 Sep; 26(3):199-204. PubMed ID: 16086309
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
